Capabilities · Packaging, assembly & serialisation

Packaging qualification

A proposed service scope for physical protection assessment, connecting material compatibility, seal integrity, transit stress evaluation and component dimensional suitability.

PlannedCatalogue scope

Illustrative unbranded blister strip and carton edge detail.
Illustrative unbranded blister strip and carton edge detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Packaging qualification is presented as a planned service domain. The exact product, primary container format, secondary protection and technical testing route would define its scope.

The initial Boten formulation-and-filling plan identifies foundational container formats without detailing transit qualification boundaries. This physical testing domain represents a proposed expansion, and any such scope would require separate confirmation.

Environmental conditioning, vibration testing and drop simulation represent distinct technical methodologies. Inclusion in a common catalogue does not establish that all physical challenges are appropriate for a particular fragile presentation.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Primary container compatibilityEvaluation of physical interaction between the formulation and direct contact materials.Catalogue scopePlanned
Secondary carton integrityAssessment of physical protection offered by printed cartons and internal dividers.Catalogue scopePlanned
Shipping configuration qualificationThermal and physical stress testing for tertiary transport boxes and pallets.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Material specification review

Define the physical characteristics, dimensions and construction of the proposed packaging items.

02 · Process stage

Planned

Risk boundary definition

Consider the potential physical shocks, thermal changes and atmospheric pressures during transit.

03 · Process stage

Planned

Test protocol generation

Establish the formal methodology for applying controlled stress to the intended packaging format.

04 · Process stage

Planned

Environmental conditioning simulation

Expose the packed unit to specific temperature and humidity profiles for defined periods.

05 · Process stage

Planned

Physical stress application

Apply controlled vibration, drop testing or compression forces to the loaded packaging unit.

06 · Process stage

Planned

Post-test evaluation

Examine the primary container and physical product for any damage, leakage or degradation.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Container-closure integrity testing

Presentation-specific integrity questions and the supporting method.

Explore proposed scope

02PlannedCatalogue scope

Stability studies

Study design, conditions, sampling and product-container relevance.

Explore proposed scope

03PlannedCatalogue scope

Cold-chain & distribution planning

Product-specific temperature, route and handling requirements.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product and format
Exact physical properties, primary container fragility and the proposed secondary packaging.
Facility and systems
Relevant installed environmental chambers, vibration tables and physical inspection tools.
Process evidence
Defined testing parameters, calibrated measurement devices and documented physical challenge results.
Quality responsibilities
Controlled protocol review, acceptance criteria definition and result decision rights.
Regulatory context
Applicable pharmacopoeial requirements for container suitability and transit protection standards.
Technical agreement
Responsibilities, test location boundaries and acceptance criteria for any qualification engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating packaging-qualification service.

Does this domain include chemical extractables testing?

No. The proposed scope considers physical protection and transit stability. Analytical extractables and leachables characterisation would require a separate technical evaluation.

What information helps define the question?

Identify the proposed product, primary container fragility, intended transport route, required temperature profile and the technical or documentation question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, physical testing evidence and any qualification agreement would need to be established before a service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma